Travere Therapeutics to Present Abstracts on FILSPARI® (sparsentan) in IgA Nephropathy at World Congress of Nephrology and the American Nephrology Nurses Association

April 3, 2024

https://www.globenewswire.com/news-release/2024/04/03/2857380/0/en/Travere-Therapeutics-to-Present-Abstracts-on-FILSPARI-sparsentan-in-IgA-Nephropathy-at-World-Congress-of-Nephrology-and-the-American-Nephrology-Nurses-Association.html

SAN DIEGO, April 03, 2024 (GLOBE NEWSWIRE) — Travere Therapeutics, Inc., (Nasdaq:TVTX) today announced that the Company will present nine abstracts in rare kidney disease at the World Congress of Nephrology (WCN) in Buenos Aires, Argentina, on April 13-16, 2024, and the American Nephrology Nurses Association (ANNA) National Symposium in Orlando, Florida, on April 14-17, 2024.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.